Corxel Pharmaceuticals
Clinical trials sponsored by Corxel Pharmaceuticals, explained in plain language.
-
New daily pill CX11 shows promise for obesity in early trial
Disease control CompletedThis completed Phase 2 study tested different doses of CX11 tablets against a placebo in 250 overweight or obese adults. Participants took the pill once daily with meals for 36 weeks, followed by a 2-week safety check. The main goal was to see how much weight people lost and whet…
Phase: PHASE2 • Sponsor: Corxel Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New drug aficamten shows promise for thick heart muscle in chinese patients
Disease control CompletedThis study tested a drug called aficamten in 40 Chinese patients with a type of heart disease where the heart muscle is too thick and blocks blood flow. The goal was to see if the drug is safe and helps the heart work better over time. Patients who had already been in a similar s…
Phase: PHASE3 • Sponsor: Corxel Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC